Xtant Medical Holdings, Inc. XTNT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -64.08%
- 1 year
- -69.54%
- Open
- 0.281
- Prev close
- 0.2904
- Mkt cap
- 39.31M
- Vol
- 44.52K
- Avg vol
- 1.69M
- EPS
- -0.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2802
- High
- 0.2964
- Forward P/E
- -13.43
- Beta
- 0.39
- Short ratio
- 6.92
- Inst. own
- 65.12%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.467
- 200-d avg
- 0.68755
- 1y target
- 2.25
News
1 week ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…
-
1 month ago benzinga.com
LUCID CAPITAL MARKETS Initiates Coverage On Xtant Medical Holdings with Buy Rating, Announces Price Target of $1
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Xtant Medical Holdings (AMEX:XTNT) with a Buy rating and announces Price Target of $1.
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market session. The company's market cap stands at $5.4 million. Alamar Biosciences (NASDAQ:ALMR) stock rose 7.4%…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's after-market session. The market value of their outstanding shares is at $144.8 million. TransCode…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) shares moved…
-
2 months ago benzinga.com
Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand
The agreement establishes BioHorizons as the exclusive distributor of Xtant's allogeneic growth factor technology into the dental and oral-maxillofacial procedure markets in the United States and…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release,…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global…
-
2 months ago benzinga.com
Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 250 percent decrease over earnings of…
-
2 months ago benzinga.com
Xtant Medical Hldgs Lowers FY2026 Sales Guidance from $101.000M-$105.000M to $99.000M-$103.000M vs $102.058M Est
Xtant Medical Hldgs (AMEX:XTNT) lowers FY2026 sales outlook from $101.000 million-$105.000 million to $99.000 million-$103.000 million vs $102.058 million estimate.
-
5 months ago benzinga.com
BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target
BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintains $1 price target.
-
5 months ago benzinga.com
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
Xtant Medical Raises FY2026 Sales Guidance from $95.000M-$99.000M to $101.000M-$105.000M vs $96.725M Est
2026 Financial GuidanceThe Company is today increasing its full-year 2026 revenue guidance to a range of $101 million to $105 million, from $95 million to $99 million previously, to reflect the…
-
5 months ago benzinga.com
Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. The company reported quarterly sales of $20.884 million which beat the analyst…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
6 months ago benzinga.com
Xtant Medical Holdings Acquires Exclusive U.S. Distribution Rights To Dilon Technologies' HEMOBLAST Bellows
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, and Dilon Technologies, Inc., a medical…
-
7 months ago benzinga.com
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1
BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $1.5 to $1.
-
7 months ago benzinga.com
Xtant Medical Hldgs Sees FY2026 Sales $95.000M-$99.000M vs $110.100M Est
Xtant Medical Hldgs (AMEX:XTNT) sees FY2026 sales of $95.000 million-$99.000 million vs $110.100 million analyst estimate.
-
7 months ago benzinga.com
Earnings Scheduled For March 31, 2026
Earnings Scheduled For March 31, 2026
-
7 months ago benzinga.com
Xtant Medical Hldgs Q4 Sales $32.357M Beat $30.750M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly sales of $32.357 million which beat the analyst consensus estimate of $30.750 million by 5.23 percent. This is a 2.68 percent increase over sales of…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
8 months ago benzinga.com
Xtant Medical Receives $10.7M Related To Companion Spine's Purchase Of Xtant's Coflex Assets And Paradigm OUS Businesses, Bringing Total Price For Two Divestitures To $21.4M
Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Companion Spine plus related working capital adjustmentsBELGRADE, Mont., March 2, 2026 /PRNewswire/ --…
9 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
11 months ago benzinga.com
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1.5
BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $2 to $1.5.
-
11 months ago benzinga.com
Xtant Medical Hldgs Affirms FY2025 Sales Guidance of $131.000M-$135.000M vs $129.950M Est
Xtant Medical Hldgs (AMEX:XTNT) affirms FY2025 sales outlook from $131.000 million-$135.000 million to $131.000 million-$135.000 million vs $129.950 million estimate.
-
11 months ago benzinga.com
Xtant Medical Hldgs Q3 EPS $0.01 Beats $(0.01) Estimate, Sales $33.300M Beat $32.700M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 300 percent. This is a 125 percent increase over losses of…
-
11 months ago benzinga.com
Earnings Preview For Xtant Medical Hldgs
Earnings Preview For Xtant Medical Hldgs
-
1 year ago benzinga.com
Xtant Medical Hldgs Raises FY2025 Sales Guidance from $127.000M-$131.000M to $131.000M-$135.000M vs $129.550M Est
Xtant Medical Hldgs (AMEX:XTNT) raises FY2025 sales outlook from $127.000 million-$131.000 million to $131.000 million-$135.000 million vs $129.550 million estimate.
-
1 year ago benzinga.com
Xtant Medical Hldgs Q2 EPS $0.02 Beats $(0.01) Estimate, Sales $30.436M Miss $31.350M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.01) by 300 percent. This is a 166.67 percent increase over losses of…
-
1 year ago benzinga.com
Earnings Scheduled For August 12, 2025
Earnings Scheduled For August 12, 2025
-
1 year ago benzinga.com
Earnings Preview For Xtant Medical Hldgs
Earnings Preview For Xtant Medical Hldgs
-
1 year ago benzinga.com
Xtant Medical Holdings, Announces The Company Has Entered Into Agreements To Sell Certain Coflex And Cofix Interlaminar Stabilization Implant Assets And All OUS Entities Of Paradigm Spine GmbH To Companion Spine LLC. Proceeds Of Transaction Total $19.2M
Xtant Medical Holdings, Inc. (NYSE:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that the…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Xtant Medical Hldgs Raises FY2025 Sales Guidance from $126.00M-$130.00M to $127.00M-$131.00M vs $128.35M Est
Xtant Medical Hldgs (AMEX:XTNT) raises FY2025 sales outlook from $126.00 million-$130.00 million to $127.00 million-$131.00 million vs $128.35 million estimate.
-
1 year ago benzinga.com
Xtant Medical Hldgs Q1 Sales $32.90M Beat $31.20M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly sales of $32.90 million which beat the analyst consensus estimate of $31.20 million by 5.46 percent. This is a 18.05 percent increase over sales of…
-
1 year ago benzinga.com
A Glimpse of Xtant Medical Hldgs's Earnings Potential
A Glimpse of Xtant Medical Hldgs's Earnings Potential
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
Xtant Medical Hldgs Sees FY2025 Revenue of $126.000M-$130.000M vs $132.85M Est
Xtant Medical Hldgs (AMEX:XTNT) sees FY2025 sales of $126.000 million-$130.000 million vs $132.85 million analyst estimate.
-
1 year ago benzinga.com
Xtant Medical Hldgs Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $31.51M Miss $31.80M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is a 33.33 percent increase over losses of…
-
1 year ago benzinga.com
Xtant Medical Hldgs Affirms FY2024 Sales Guidance from $116.00M-120.00M to $116.00M-$120.00M
Xtant Medical Hldgs (AMEX:XTNT) affirms FY2024 sales outlook from $116.00 million-120.00 million to $116.00 million-120.00 million.
-
1 year ago benzinga.com
Xtant Medical Hldgs Q3 2024 GAAP EPS $(0.04) Misses $(0.03) Estimate, Sales $27.937M Miss $29.300M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. The company reported quarterly sales of $27.937…
-
1 year ago benzinga.com
Earnings Scheduled For November 12, 2024
Earnings Scheduled For November 12, 2024
-
1 year ago benzinga.com
Xtant Medical Hldgs's Earnings Outlook
Xtant Medical Hldgs's Earnings Outlook
-
2 years ago benzinga.com
Xtant Medical Expands Product Portfolio With The Launch Of The Cortera Posterior Fixation System
New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE:XTNT), a…
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
2 years ago benzinga.com
BTIG Maintains Buy on Xtant Medical Hldgs, Raises Price Target to $3
BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target from $2 to $3.